curesconference

[curesconference @curesconference]

Dr. Shoshana Shendelman discusses commonalities between Alzheimer’s and Parkinson’s diseases and what they could mean for advancing treatment. Watch the full session on YouTube: https://t.co/q3KgEUAX9Q

[curesconference @curesconference]

Scalability is key to ensuring drug development can reach patients worldwide. Louis Reese shares why the right technology should be in place to make global access possible. Watch the full session on YouTube: https://t.co/lJISrqaho5

[curesconference @curesconference]

Dr. Shoshana Shendelman and Louis Reese discuss how technology accessibility is critical for treatment development. Watch the full session on YouTube: https://t.co/7dQNe3yHFX

[curesconference @curesconference]

NORD has always been a resource in rare disease research. John Greally shares insights on how it’s been beneficial across the industry. Watch the full session on YouTube: https://t.co/7kmD9ppxR0

[curesconference @curesconference]

The accelerated approval pathway is essential to bringing rare disease treatments to patients. Tap in as Dr. Shoshana Shendelman, Edward Neilan, and John Greally discuss at the Cures Conference.
Watch the full session on YouTube: https://t.co/LRjgYFqcCA

[curesconference @curesconference]

Dr. Shoshana Shendelman, John Greally, and Edward Neilan discuss the future of technology in rare diseases.

#research #biotechnology #RareDisease

[curesconference @curesconference]

Why is Long-read Sequencing transforming rare disease diagnosis? Shoshana Shendelman, PhD, John Greally, and Edward Neilan, MD, PhD discuss at the Cures Conference. Watch the full Session 2 on YouTube: https://t.co/te7aP3wKa7

[curesconference @curesconference]

Shoshana Shendelman, PhD and John Greally discuss how a disease that is rare globally may be common locally: Hypertrophic Cardiomyopathy in the Garifuna community in the Bronx.

[curesconference @curesconference]

Improving global health outcomes requires collaboration across every corner of science. Biotech, pharma, technology, and policy. When researchers, innovators, and industry leaders align, we accelerate breakthroughs, and create scalable solutions that reach patients worldwide.

[curesconference @curesconference]

What If the Key to Rare Disease Cures Was Hidden in Cancer Research?

[curesconference @curesconference]

Can AI Replace Animal Testing?

By leveraging predictive modeling and human relevant data, AI can evaluate safety and efficacy earlier in the development process. This not only accelerates discovery but also supports more ethical, efficient pathways to new therapies.

[curesconference @curesconference]

AI is transforming the drug development timeline.

By analyzing massive datasets in minutes, identifying viable compounds faster, and predicting clinical success with greater precision, AI is reducing years of trial-and-error into smarter, data-driven decisions.

[curesconference @curesconference]

At Cures Conference, Dr. Shoshana Shendelman spoke on the democratization of AI. Highlighting how expanding access to advanced technology is accelerating drug development, increasing probability of success, and bringing life-saving treatments closer to patients faster 💡🧬
#tech

[curesconference @curesconference]

AI is helping reduce reliance on animal testing in drug development.

Predictive models can simulate biology, assess toxicity, and optimize compounds earlier — improving precision and accelerating timelines.

Smarter science. Better outcomes.

#AI #DrugDiscovery #Biotech

[curesconference @curesconference]

AI is transforming drug development by compressing timelines and improving probability of success. Advanced models are enabling faster target identification, precise molecule design, and smarter clinical insights. Reducing risk while accelerating the path to life-saving therapies

[curesconference @curesconference]

AI in drug development is no longer limited by geography.
It’s accelerating life-saving drug discovery across borders.

Enabling collaboration between researchers, institutions, and innovators worldwide.

When AI scales globally, so does access, innovation, and economic growth.

[curesconference @curesconference]

Over the last 5 years, AI has dramatically accelerated the development of life-saving drugs.

Jack Hidary explains how smarter models + faster discovery cycles are changing what’s possible in biotech.
#DrugDiscovery #Biotech #AI #pharma

[curesconference @curesconference]

What are biotech leaders actually doing with AI right now?

In this clip, Jack Hidary and Nadia Harhen share how they’re using AI to accelerate target discovery, optimize molecules, and improve clinical decision-making.

AI in drug development isn’t coming — it’s here.

[curesconference @curesconference]

AI isn’t the future of drug discovery. It’s the now. At Cures Conference Session 1, industry leaders break down how AI is accelerating drug innovation. The result? Shorter timelines. Lower costs. And life-saving treatments reaching patients sooner Watch the full sess on YouTube🔗

[curesconference @curesconference]

The CURES Conference kicks off today, bringing together leaders in science, tech, and healthcare to explore the innovations shaping the future of global health. From AI-driven drug discovery to expanding life-saving access, today’s conversations are about real impact🔬🌍